Lung Isolation in Thoracic Surgery - a Randomized Trial Comparing the VivaSight™ EB Endobronchial Blocker With Established Devices
NCT ID: NCT02912598
Last Updated: 2016-09-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
104 participants
INTERVENTIONAL
2015-01-31
2015-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prospective, Randomized Clinical Trial Evaluating the ETView Double-Lumen Tube
NCT01807676
A Study of Venoarterial ECMO vs Off-Pump Bilateral Orthotopic Lung Transplantation
NCT05547698
VivaSight-SL™ Versus Bronchoscopy for Percutaneous Tracheotomy
NCT02861001
To Compare Endotracheal Tube (ET) With Subglottic Suction Drainage and Standard ET in the Incidence of VAP
NCT03101202
Endotracheal Tubes to Prevent Ventilator-Associated Pneumonia
NCT03705286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Mallinckrodt™ Endobronchial Tube
Usage of a left-sided Mallinckrodt™ double-lumen tube (DLT) to achieve lung isolation and one lung ventilation.
Mallinckrodt™ Endobronchial Tube
Fuji Uniblocker™
Usage of a Fuji Uniblocker™ in a generic single-lumen tube to achieve lung isolation and one lung ventilation.
Fuji Uniblocker™
ETView VivaSight™-SL+EB
Usage of a ETView VivaSight™-EB endobronchial blocker in a ETView VivaSight™-SL single-lumen tube to achieve lung isolation and one lung ventilation.
ETView VivaSight™-SL+EB
COOK© Arndt Endobronchial Blocker
Usage of a COOK© Arndt Endobronchial Blocker in a generic single-lumen tube to achieve lung isolation and one lung ventilation.
COOK© Arndt Endobronchial Blocker
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Mallinckrodt™ Endobronchial Tube
Fuji Uniblocker™
ETView VivaSight™-SL+EB
COOK© Arndt Endobronchial Blocker
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* scheduled for elective thoracic surgery with one-lung ventilation
* written informed consent in anaesthesia, the study and anonymized data collection
Exclusion Criteria
* one-lung ventilation impossible to establish
* denial of the study or data collection
* surgical or anatomical circumstances preventing the use of a double-lumen tube
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Otto-von-Guericke University Magdeburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Tom Kreft
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas Hachenberg, Prof. Dr. med.
Role: STUDY_CHAIR
Klinik für Anaesthesiologie und Intensivtherapie der Otto-von-Guericke-Universität / Medizinische Fakultät Universitätsklinikum Magdeburg A.ö.R.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
142/14
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.